Mallinckrodt Earns Top Marks Again in Human Rights Campaign Foundation's 2022 Corporate Equality Index
DUBLIN, Jan. 31, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, announced that it received a score of 100 on the Human Rights Campaign Foundation's 2022 Corporate Equality Index, the U.S.'s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. Mallinckrodt joins over 840 major U.S. businesses that also earned top marks this year.
"We're extremely proud that for the sixth straight year, the HRC Foundation has recognized our organization's commitment to fostering an inclusive and diverse culture for all of our employees," said Mark Trudeau, President and Chief Executive Officer, Mallinckrodt. "Mallinckrodt's deep, ongoing commitment to inclusion and diversity is central to our values and helps enable our employees' passion for creating new drugs and therapies to support underserved patients suffering from severe and critical conditions. As a company, we are enriched and strengthened by the experiences, perspectives, contributions and successes all our employees bring."
"When the Human Rights Campaign Foundation created the Corporate Equality Index 20 years ago, we dreamed that LGBTQ+ workers—from the factory floor to corporate headquarters, in big cities and small towns—could have access to the policies and benefits needed to thrive and live life authentically," said Jay Brown, Human Rights Campaign Senior Vice President of Programs, Research and Training. "We are proud that the Corporate Equality Index paved the way to that reality for countless LGBTQ+ workers in America and abroad. But there is still more to do, which is why we are raising the bar yet again to create more equitable workplaces and a better tomorrow for LGBTQ+ workers everywhere. Congratulations to Mallinckrodt for achieving the title of 'best places to work for LGBTQ+ equality' and working to advance inclusion in the workplace."
The results of the 2022 CEI showcase how 1,271 U.S.-based companies are not only promoting LGBTQ+-friendly workplace policies in the U.S., but also how for the
In 2002, the first year of the CEI, only 13 companies achieved a top-score, demonstrating the incredible impact the CEI has had on the business world over its 20-year life. This year's CEI reflects growth across every measurement category, from the adoption of inclusive non-discrimination policies, to equitable healthcare benefits for transgender employees.
The CEI rates employers providing these crucial protections to over 20 million U.S. workers and an additional 18 million abroad. Companies rated in the CEI include Fortune magazine's 500 largest publicly traded businesses, American Lawyer magazine's top 200 revenue-grossing law firms (AmLaw 200), and hundreds of publicly and privately held mid- to large-sized businesses.
The CEI rates companies on detailed criteria falling under four central pillars:
- Non-discrimination policies across business entities;
- Equitable benefits for LGBTQ+ workers and their families;
- Supporting an inclusive culture; and,
- Corporate social responsibility.
The full report is available online at www.hrc.org/cei.
About The Human Rights Campaign
The Human Rights Campaign Foundation is the educational arm of the Human Rights Campaign (HRC), America's largest civil rights organization working to achieve equality for lesbian, gay, bisexual, transgender and queer (LGBTQ+) people. Through its programs, the HRC Foundation seeks to make transformational change in the everyday lives of LGBTQ+ people, shedding light on inequity and deepening the public's understanding of LGBTQ+ issues, with a clear focus on advancing transgender and racial justice. Its work has transformed the landscape for more than 15 million workers, 11 million students, 1 million clients in the adoption and foster care system and so much more. The HRC Foundation provides direct consultation and technical assistance to institutions and communities, driving the advancement of inclusive policies and practices; it builds the capacity of future leaders and allies through fellowship and training programs; and, with the firm belief that we are stronger working together, it forges partnerships with advocates in the U.S. and around the globe to increase our impact and shape the future of our work.
About Mallinckrodt
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
CONTACT
Media Inquiries
Jamie Tinsley
H+K Strategies
jamie.tinsley@hkstrategies.com
M: +1 713 301 4874
Ron Bartlet
H+K Strategies
ron.bartlett@hkstrategies.com
M: +1 813 545 2399
Investor Relations
Daniel J. Speciale
Global Corporate Controller & Chief Investor Relations Officer
daniel.speciale@mnk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-earns-top-marks-again-in-human-rights-campaign-foundations-2022-corporate-equality-index-301471221.html
SOURCE Mallinckrodt plc
